The big biotech opportunity

CITY

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

The technology-led US stockmarket has hit another record peak. There are rumours of stonking pay packages for software developers in Silicon Valley. One of the leading tech behemoths has just achieved

Companies in the news and how they were assessed

The last 50 years have been kind to investors in real terms. Everything made money: equities, bonds, property and gold. All investors had to remember was not to buy high and sell low. But that hasn’t